Available studies suggest that LBX2-AS1 exerts a promotive effect in tumors such as glioma, colorectal cancer, osteosarcoma, ovarian cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, and thyroid cancer. This evidence concerns the gene LBX2 and central nervous system cancer.